Search by Drug Name or NDC

    NDC 54436-0200-05 XYOSTED 100 mg/.5mL Details

    XYOSTED 100 mg/.5mL

    XYOSTED is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Antares Pharma, Inc.. The primary component is TESTOSTERONE ENANTHATE.

    Product Information

    NDC 54436-0200
    Product ID 54436-200_cb6917b9-70b7-45be-9f4e-b1c55938bf9b
    Associated GPIs 2310003020D540
    GCN Sequence Number 079087
    GCN Sequence Number Description testosterone enanthate AUTO INJCT 100 MG/0.5 SUBCUT
    HIC3 F1A
    HIC3 Description ANDROGENIC AGENTS
    GCN 45519
    HICL Sequence Number 001401
    HICL Sequence Number Description TESTOSTERONE ENANTHATE
    Brand/Generic Brand
    Proprietary Name XYOSTED
    Proprietary Name Suffix n/a
    Non-Proprietary Name testosterone enanthate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/.5mL
    Substance Name TESTOSTERONE ENANTHATE
    Labeler Name Antares Pharma, Inc.
    Pharmaceutical Class Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
    DEA Schedule CIII
    Marketing Category NDA
    Application Number NDA209863
    Listing Certified Through 2025-12-31

    Package

    NDC 54436-0200-05 (54436020005)

    NDC Package Code 54436-200-05
    Billing NDC 54436020005
    Package 1 SYRINGE in 1 CARTON (54436-200-05) / .5 mL in 1 SYRINGE (54436-200-02)
    Marketing Start Date 2024-01-08
    NDC Exclude Flag N
    Pricing Information N/A